Granules India Limited (GRANULES.NS)

INR 596.4

(-0.07%)

Market Cap (In INR)

144.54 Billion

Revenue (In INR)

45.06 Billion

Net Income (In INR)

4.05 Billion

Avg. Volume

3.5 Million

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
365.45-721.0
PE
-
EPS
-
Beta Value
0.21
ISIN
INE101D01020
CUSIP
Y2849A135
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D.
Employee Count
-
Website
https://www.granulesindia.com
Ipo Date
2005-06-20
Details
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.